Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LE 300 represents a structurally novel type of antagonists acting preferentially at the dopamine D(1)/D(5)receptors and the serotonin 5-HT(2A)receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | Inquiry | $ 1,298.00 |
Description | LE 300 represents a structurally novel type of antagonists acting preferentially at the dopamine D(1)/D(5)receptors and the serotonin 5-HT(2A)receptor. |
Targets&IC50 | dopamine D1 receptor:1.9 nM (Ki,Human), 5-HT2A:8.32 (pA2,rat), dopamine D5 receptor:7.5 nM (Ki,Human) |
In vitro | The Kis of LE 300 are 1.9 nM and 7.5 nM in CHO cell membranes expressing human dopamine D1 and D5 receptors, respectively. In a rat tail artery experiment, the pA2 value of LE 300 at the 5-HT2A receptor was 8.32[2]. |
Molecular Weight | 290.4 |
Formula | C20H22N2 |
CAS No. | 274694-98-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1eq. HCl: <15 mg/ml(51.65 mM)
DMSO: <30 mg/ml(103.30 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LE 300 274694-98-3 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor inhibit Inhibitor LE300 LE-300 Serotonin Receptor 5-hydroxytryptamine Receptor inhibitor